1. Signaling Pathways
  2. Metabolic Enzyme/Protease
  3. Carbamoyl Phosphate Synthetase (CPS)

Carbamoyl Phosphate Synthetase (CPS) (氨基甲酰磷酸合成酶)

CPS

氨甲酰磷酸合成酶 (CPS) 是一种参与氮代谢及嘧啶合成的酶,根据其位置和功能的不同,可分为两种异构体:CPS I 和 CPS II。CPS I 主要在肝脏线粒体内发挥作用,参与尿素循环的第一步反应,催化氨 (NH3) 和二氧化碳(CO2)在ATP的作用下合成碳酰磷酸,从而帮助将体内过量的氨转化为无毒的尿素,排出体外。CPS II 则主要存在于细胞质中,参与嘧啶核苷酸的生物合成,其催化的碳酰磷酸用于合成嘧啶前体,进而支持DNA和RNA的合成。
氨甲酰磷酸合成酶在代谢和生理过程中具有至关重要的作用。CPS I 缺乏症是一种遗传性代谢障碍,导致尿素循环受阻,氨在体内积聚,造成高氨血症,进而引发昏迷、癫痫及其他神经系统症状。CPS II 缺乏症则可能导致嘧啶合成异常,进而影响细胞增殖及免疫功能,且与某些肿瘤的发生和进展相关[1]

Carbamoyl Phosphate Synthetase (CPS) is an enzyme involved in nitrogen metabolism and pyrimidine synthesis. It exists in two isoforms, CPS I and CPS II, based on their location and function. CPS I primarily operates in the mitochondria of the liver, participating in the first step of the urea cycle. It catalyzes the synthesis of carbamoyl phosphate from ammonia (NH3) and carbon dioxide (CO2) in the presence of ATP, helping to convert excess ammonia in the body into non-toxic urea for excretion. CPS II, on the other hand, is mainly found in the cytoplasm and is involved in the biosynthesis of pyrimidine nucleotides. The carbamoyl phosphate it catalyzes is used to synthesize pyrimidine precursors, thereby supporting DNA and RNA synthesis.
Carbamoyl Phosphate Synthetase plays a crucial role in metabolism and physiological processes. CPS I deficiency is a hereditary metabolic disorder that leads to impaired urea cycle function, causing the accumulation of ammonia in the body, resulting in hyperammonemia, which can trigger coma, seizures, and other neurological symptoms. CPS II deficiency may lead to abnormal pyrimidine synthesis, affecting cell proliferation and immune function, and is associated with the occurrence and progression of certain cancers[1].

Carbamoyl Phosphate Synthetase (CPS) 相关产品 (1):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-121132
    Butibufen Inhibitor
    Butibufen 是一种具有口服活性的非甾体化合物。Butibufen 具有止痛和解热的特性。Butibufen 可用于炎症的研究。
    Butibufen